HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Gastric Cancer Surgery

Gastric cancer surgery is a medical procedure aimed at removing cancerous tissues from the stomach. This type of surgery is typically recommended when other treatments, such as chemotherapy or radiation therapy, are not sufficient or when the cancer is confined to the stomach and has not spread extensively. During gastric cancer surgery, the surgeon may employ different techniques based on the extent and location of the cancer. One common approach is partial or total gastrectomy, where a portion or the entire stomach is removed. In some cases, nearby lymph nodes and surrounding tissues may also be excised to prevent the spread of cancer cells. Post-surgery, patients may experience changes in their digestive system, and dietary adjustments are often necessary. The recovery period varies depending on the type and extent of the surgery, with some individuals returning to their normal activities relatively quickly, while others may require a more extended recovery period. As with any surgical procedure, there are potential risks and complications associated with gastric cancer surgery. These can include infection, bleeding, and adverse reactions to anesthesia. However, advancements in surgical techniques and preoperative care have improved overall outcomes and reduced the risk of complications. After surgery, patients will typically undergo regular follow-up appointments to monitor their recovery and address any potential issues. Adherence to postoperative care instructions, including dietary guidelines and rehabilitation exercises, is crucial for a successful recovery. In conclusion, gastric cancer surgery plays a vital role in the comprehensive treatment of stomach cancer. It aims to remove cancerous tissues, prevent the spread of the disease, and improve the patient's overall quality of life. Advances in medical technology and treatment strategies continue to enhance the effectiveness of gastric cancer surgery and contribute to better outcomes for individuals diagnosed with this form of cancer.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp